Uncover key drivers, emerging technologies, and competitive movements shaping the fluorescent in situ hybridization probe market from 2025–2034 with trusted insights from The Business Research Company

What Is The Projected Valuation Of The Fluorescent In Situ Hybridization Probe Market In The Coming Years?

The fluorescent in situ hybridization probe market has experienced substantial expansion in recent years. Its valuation is projected to increase from $1.55 billion in 2024 to $1.68 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.8%. Historically, this growth stemmed from the escalating use of cytogenetic analysis in prenatal examinations, an uptick in academic research concerning chromosomal anomalies, the broader application of FISH for microbial identification, an increase in government-supported genomics research, and enhanced capabilities within pathology laboratories.

The fluorescent in situ hybridization probe market size is projected to experience significant expansion over the coming years. It is expected to grow to $2.23 billion by 2029, achieving a compound annual growth rate (CAGR) of 7.4%. This projected growth can be attributed to several factors during the forecast period, including the increasing adoption of these probes in research and diagnostics, a rising demand for multiplexed probe solutions for rare disease diagnosis, a growing emphasis on automation within cytogenetic testing workflows, the expanding application of FISH in liquid biopsy, and its increasing use in plant and animal genomics research. Prominent trends anticipated in the forecast period involve advancements in probe signal amplification techniques, the development of nano-enabled FISH platforms, innovations in automation-compatible FISH assay kits, the sophisticated application of machine learning in probe design, and the broadening of 3D FISH imaging applications.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27289&type=smp

Which Growth Drivers Are Shaping The Fluorescent In Situ Hybridization Probe Market Outlook?

The fluorescent in situ hybridization probe market is expected to expand due to the increasing adoption of personalized medicine. This medical model, personalized medicine, involves customizing treatments and healthcare by using information about a person’s genes and lifestyle environment to meet their specific needs. The growing embrace of personalized medicine is attributed to individuals preferring health technologies that provide real-time monitoring and treatment plans tailored to their unique biology. Fluorescent in situ hybridization (FISH) probes support personalized medicine by enabling the precise detection of genetic abnormalities at the chromosomal level, thereby guiding customized therapeutic decisions based on an individual’s unique genetic profile. For instance, in February 2023, the Personalized Medicine Coalition, a US-based professional membership organization, indicated that in 2022, the approval of 12 new personalized medicines accounted for approximately 34% of all newly approved therapies, showing a substantial rise from prior years. Consequently, the increasing adoption of personalized medicine is driving the growth of the fluorescent in situ hybridization probe market.

What Is The Segment Breakdown Of The Fluorescent In Situ Hybridization Probe Market?

The fluorescent in situ hybridization probe market covered in this report is segmented

1) By Type: Deoxyribonucleic Acid (DNA) Probes, Ribonucleic Acid (RNA) Probes, Multiplex Probes

2) By Target: Genes, Chromosomes, Other Targets

3) By Technology: Single-Color Fluorescence In Situ Hybridization (FISH), Multiplex Fluorescence In Situ Hybridization (FISH), Quantitative Fluorescence In Situ Hybridization (FISH), Others Technologies

4) By Application: Clinical Diagnostics, Research Applications, Agricultural Biotechnology, Pharmaceutical Research, Genetic Research

5) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Deoxyribonucleic Acid (DNA) Probes: Centromeric Probes, Telomeric Probes, Whole Chromosome Paint Probes, Locus-Specific Identifier (LSI) Probes, Comparative Genomic Hybridization (CGH) Probes, Gene Fusion Probes

2) By Ribonucleic Acid (RNA) Probes: mRNA Probes, Long Non-Coding RNA (lncRNA) Probes, MicroRNA (miRNA) Probes, Single-Molecule RNA FISH Probes (smFISH), Circular RNA (circRNA) Probes, Multiplexed Error-Robust FISH (MERFISH) Probes

3) By Multiplex Probes: Multicolor DNA FISH Probes, Multigene Expression Analysis Probes, High-Throughput Screening Probes, Multiplex smFISH Probes, Combinatorial Barcoded Probes, Simultaneous DNA/RNA Detection Probes

How Are Global Trends Impacting The Development Of The Fluorescent In Situ Hybridization Probe Market?

Companies operating in the fluorescent in situ hybridization probe market are increasingly concentrating on forming strategic collaborations to gain access to new markets, technologies, or expertise that might otherwise be difficult or expensive to develop independently. A strategic collaboration is defined as a planned partnership between two or more entities that combine their strengths and resources to achieve shared long-term objectives and mutual benefits. For example, in April 2025, Empire Genomics, a US-based molecular diagnostics company, partnered with BioDot, a US-based provider of precision dispensing automation, to introduce the BDot Probe Line. This BDot Probe Line presents a unique solution by offering FISH probes that are pre-optimized for automated systems, thereby addressing a critical challenge within clinical cytogenetics and molecular pathology labs. These probes are engineered for direct application without requiring manual adjustments, ensuring seamless functionality with the Biodot CellWriter S system. This innovation minimizes the need for technician intervention, streamlines workflows, and accelerates the time needed to obtain results. The initial set of BDot Probe Panels supports FISH analysis for a broad spectrum of blood-related cancers, including MM, MDS, CML, AML, ALL, and other prevalent hematologic conditions.

Who Are The Major Stakeholders Operating In The Fluorescent In Situ Hybridization Probe Market?

Major companies operating in the fluorescent in situ hybridization probe market are Thermo Fisher Scientific Inc., Abbott Laboratories, Oxford Gene Technology IP Limited, Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Leica Biosystems Nussloch GmbH, Biocare Medical LLC, Enzo Biochem Inc., LGC Biosearch Technologies, ZytoVision GmbH, Creative Biolabs Inc., Empire Genomics LLC, MetaSystems GmbH, Abnova Corporation, Mirus Bio LLC, Genemed Biotechnologies Inc., Molecular Instruments Inc., and Cytocell Technologies Limited.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/fluorescent-in-situ-hybridization-probe-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Fluorescent In Situ Hybridization Probe Market?

North America was the largest region in the fluorescent in situ hybridization probe market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluorescent in situ hybridization probe market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27289&type=smp

Browse Through More Reports Similar to the Global Fluorescent In Situ Hybridization Probe Market 2025, By The Business Research Company

Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insurance-global-market-report

Home Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/home-insurance-global-market-report

Embedded Insurance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/embedded-insurance-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model